StonvexLoading…
StonvexStonvexStonvexCore line items from FFIV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $3.09B | $2.82B | $2.81B | $2.70B |
Operating Income | $765.95M | $658.59M | $472.57M | $403.79M |
Net Income | $692.38M | $566.78M | $394.95M | $322.16M |
EPS (Diluted) | $11.80 | $9.55 | $6.55 | $5.27 |
Total Assets | $6.32B | $5.61B | $5.25B | $5.28B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.34B | $1.07B | $797.16M | $758.01M |
Free Cash Flow OCF − CapEx | $906.41M | $762.01M | $599.23M | $409.01M |
Shares Outstanding | 57.68M | 58.09M | 59.21M | 59.86M |